학술논문
A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results
Document Type
Abstract
Author
Source
In Blood 15 November 2013 122(21):3335-3335
Subject
Language
ISSN
0006-4971